BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12749762)

  • 1. Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.
    Bashir O; Fitzgerald AJ; Berlanga-Acosta J; Playford RJ; Goodlad RA
    Clin Sci (Lond); 2003 Sep; 105(3):323-30. PubMed ID: 12749762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development.
    Mandir N; Englyst H; Goodlad RA
    Br J Nutr; 2008 Oct; 100(4):711-21. PubMed ID: 18279550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC in the regulation of intestinal crypt fission.
    Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA
    J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of epidermal growth factor and dimethylhydrazine on crypt size, cell proliferation, and crypt fission in the rat colon. Cell proliferation and crypt fission are controlled independently.
    Park HS; Goodlad RA; Ahnen DJ; Winnett A; Sasieni P; Lee CY; Wright NA
    Am J Pathol; 1997 Sep; 151(3):843-52. PubMed ID: 9284833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse.
    Bashir O; FitzGerald AJ; Goodlad RA
    Carcinogenesis; 2004 Aug; 25(8):1507-15. PubMed ID: 15016659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
    Lee J; Hargest R; Wasan H; Phillips RK
    Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
    Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
    Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.
    Huerta S; Irwin RW; Heber D; Go VL; Koeffler HP; Uskokovic MR; Harris DM
    Cancer Res; 2002 Feb; 62(3):741-6. PubMed ID: 11830528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
    Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
    Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver.
    Steffensen IL; Schut HA; Alexander J
    Mutat Res; 2005 Nov; 587(1-2):73-89. PubMed ID: 16202642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betacellulin stimulates growth of the mouse intestinal epithelium and increases adenoma multiplicity in Apc+/Min mice.
    Dahlhoff M; Horst D; Gerhard M; Kolligs FT; Wolf E; Schneider MR
    FEBS Lett; 2008 Aug; 582(19):2911-5. PubMed ID: 18656477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL; Kettunen AS; Rautonen NE
    Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
    Hassan AB; Howell JA
    Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
    Watson SA; Smith AM
    Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
    Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
    Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of the small intestine and colon epithelia of adenomatous polyposis coli gene-mutant mice by two-dimensional gel electrophoresis.
    Minowa T; Ohtsuka S; Sasai H; Kamada M
    Electrophoresis; 2000 May; 21(9):1782-6. PubMed ID: 10870965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route, and timing of administration.
    Shin CE; Helmrath MA; Falcone RA; Fox JW; Duane KR; Erwin CR; Warner BW
    J Surg Res; 1998 Jun; 77(1):11-6. PubMed ID: 9698525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of interleukin-11 and epidermal growth factor on residual small intestine after experimental extensive small bowel resection].
    György L; Gábor B; Fiore N; Grosfeld JL; Pál O
    Magy Seb; 2006 Apr; 59(2):122-8. PubMed ID: 16784036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.